293 filings
8-K
RCKT
Rocket Pharmaceuticals, Inc.
11 Sep 24
Departure of Directors or Certain Officers
4:06pm
S-3ASR
RCKT
Rocket Pharmaceuticals, Inc.
16 Aug 24
Automatic shelf registration
4:06pm
10-Q
2024 Q2
RCKT
Rocket Pharmaceuticals, Inc.
Quarterly report
6 Aug 24
4:15pm
8-K
RCKT
Rocket Pharmaceuticals, Inc.
5 Aug 24
Rocket Pharmaceuticals Reports Second Quarter 2024 Financial Results and Highlights Recent Progress
4:17pm
8-K
RCKT
Rocket Pharmaceuticals, Inc.
28 Jun 24
Rocket Pharmaceuticals Provides Regulatory Update on About Leukocyte Adhesion Deficiency-I
4:05pm
8-K
wsh6kc
20 Jun 24
Amendments to Articles of Incorporation or Bylaws
4:02pm
8-K
v1t0 kw82mgo
6 May 24
Rocket Pharmaceuticals Reports First Quarter 2024 Financial Results and Highlights Recent Progress
5:26pm
ARS
ut249hk9n rh0b
29 Apr 24
Annual report to shareholders
4:45pm
DEFA14A
r1xnjz6
29 Apr 24
Additional proxy soliciting materials
4:43pm
8-K
53n7yv ylzoo
29 Mar 24
Rocket Pharmaceuticals Announces Appointment of Aaron Ondrey as Chief Financial Officer and Additional Updates to Corporate Leadership Team
5:17pm
8-K
rw1m9exskpymunev
26 Feb 24
Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Progress
4:37pm
8-K
k5qbjwnid5m7iqzn
13 Feb 24
Other Events
4:37pm
8-K
z4ih7k0a6qxpt6b
13 Dec 23
Departure of Directors or Certain Officers
4:05pm
8-K
hacdui2mmcr4jmakqg
2 Oct 23
Other Events
4:05pm
424B5
1xnu8 2ovrum674o7
20 Sep 23
Prospectus supplement for primary offering
4:09pm